Replies to post #1089 on GTC Biotherapeutics (fka GTCB)

[quantumdot]

Remember that LFB bring a lot to the table in terms of development investment made to date. GTC brings their IP around the process and LFB bring all of their protein IP and experience as well as their sunk costs on rhFVIIa. It goes both ways.

[DewDiligence]

I concur with quantumdot’s post (#1095). The 50/50 split of costs and profits going forward takes into account the respective contributions of the two parties to date.